Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Adhere to 14-Day Limit for PRN Psychotropic Medication

Houlton, Maine Survey Completed on 05-22-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure compliance with the 14-day limit for as needed (prn) psychotropic medication use, specifically Haldol, for one resident receiving palliative care. The resident's physician order set included a prn Haldol order for agitation without a stop date or documented clinical rationale for continued use beyond the required timeframe. Review of the treatment administration record showed that after the 14-day limit had passed, the resident received 17 additional doses of prn Haldol without a provider evaluation or documentation supporting the ongoing need for the medication. An interview with the Nurse Manager/Supervisor confirmed the absence of required documentation and provider review regarding the continued administration of prn Haldol, and the provider's progress notes did not address the medication's use during a subsequent visit. The deficiency centers on the lack of timely provider evaluation and documentation for the continued use of a psychotropic medication beyond regulatory limits, as well as the administration of multiple doses after the required review period had expired.

An unhandled error has occurred. Reload 🗙